All Updates

All Updates

icon
Filter
Product updates
ConcertAI launches predictive and GenAI solutions for oncology research
Clinical Trial Technology
May 31, 2024
This week:
Product updates
Pimax announces compact Dream Air VR headset for USD 1,900
Extended Reality
Dec 23, 2024
Funding
HuLoop raises Series A funding from Mighty Capital
Workflow Automation Platforms
Dec 23, 2024
M&A
Fiserv to acquire Payfare for undisclosed sum to enhance embedded finance solutions
Financial Wellness Tools
Dec 23, 2024
M&A
Fiserv to acquire Payfare for undisclosed sum to enhance embedded finance solutions
FinTech Infrastructure
Dec 23, 2024
Funding
Meight raises EUR 3.4 million in funding led by Cusp Capital
Smart Mobility Information
Dec 23, 2024
Regulation/policy
Desktop Metal sues Nano Dimension over merger compliance
Additive Manufacturing
Dec 23, 2024
Management news
Nexa3D scales back operations amid financial crisis
Additive Manufacturing
Dec 23, 2024
Funding
Fraction AI raises USD 6 million in pre-seed funding to scale hybrid data labeling
Machine Learning Infrastructure
Dec 23, 2024
Last week:
Partnerships
Rocket Lab launches sixth Synspective radar satellite as part of ongoing partnership
Space Travel and Exploration Tech
Dec 21, 2024
Partnerships
EHang partners with Changan Automobile to develop eVTOL aircraft for personal transportation
Passenger eVTOL Aircraft
Dec 21, 2024
Clinical Trial Technology

Clinical Trial Technology

May 31, 2024

ConcertAI launches predictive and GenAI solutions for oncology research

Product updates

  • AI-powered health and life sciences firm ConcertAI has unveiled its new predictive and GenAI solutions, expansions in partnerships, and a clinical oncology suite designed to enhance research capabilities and support complex clinical study workflows. These solutions aim to provide researchers with enhanced in-depth data analysis facilities, contributing to the creation of new care strategies to improve patient outcomes.

  • The company’s new GenAI solutions include 1) CARA AI, a comprehensive multi-modal data management platform designed to advance research across multiple fields, support collaborations, and manage multi-modal real-world data, and 2) TriaLinQ, a clinical trial screening system (as part of ConcertAI’s oncology quality management platform SmartLinQ) capable of screening 3x more patients than electronic medical records (EMR)-based screening.

  • The Massachusetts-based company offers an oncology-focused Saas platform that incorporates real-world data (RWD) to support drug developers and pharmaceutical companies in expediting drug discovery and development. It reportedly maintains the largest oncology database in the industry, with data gathered from various sources, including the FDA. It also offers clinical trial technology support platforms that assist with clinical trial management specializing in solutions for oncology-related trials.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.